Search - tctmd.com

Displaying 761 - 780 of 1731

Sort: Relevancy | Date

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation TCT 2017

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Presenter: Julinda Mehilli, Giulio G. Stefanini, Raffaele Piccolo

October 30, 2017

Presentation TCT 2017

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Drug-Coated Balloons in the Lower Extremity: Impact and Lessons Learned

Presenter: Michael Guiry, Julie Logan, Craig M. Walker

October 30, 2017

Presentation TCT 2017

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Daniel Chamie

October 30, 2017

Presentation TCT 2017

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Alessio G La Manna

October 30, 2017

Presentation TCT 2017

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Presenter: Fernando Alfonso, Jose P.S. Henriques

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Presentation TCT 2017

The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds

Presenter: Michael Guiry, Julie Logan

October 30, 2017

Presentation TCT 2017

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Javier Suárez de Lezo

October 30, 2017

Presentation TCT 2017

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Mitchell W. Krucoff

October 30, 2017

Presentation TCT 2017

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Presenter: Stephan Achenbach, Salvatore Brugaletta, Petr Tousek

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

What Is the Future of Bioabsorbable Scaffolds?

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Next Generation BRS Platforms

Presenter: Gary S. Mintz, Seung-Jung Park, Alan C. Yeung

October 29, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Outcomes 2017

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Jochen Wöhrle

October 29, 2017

Presentation TCT 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Lessons from the ABSORB Clinical Program for the Future

Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys

October 29, 2017

Advertisement

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Case #5: How to Implant Bioresorbable Scaffolds in Calcified Lesions (With Discussion)

Drug-Coated Balloons in the Lower Extremity: Impact and Lessons Learned

Case #4: How to Use Imaging During Bioresorbable Scaffold Implantation (With Discussion)

Case #3: How to Implant Bioresorbable Scaffolds in CTO (With Discussion)

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Live From Denver: TCT 2017, Day One

The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds

Case #2: How to Implant Bioresorbable Scaffolds in Bifurcation Lesions (With Discussion)

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

Case #1: How to Implant Bioresorbable Scaffolds in STEMI (With Discussion)

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

What Is the Future of Bioabsorbable Scaffolds?

Next Generation BRS Platforms

Bioresorbable Scaffolds and Outcomes 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Lessons from the ABSORB Clinical Program for the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content